Home>Topics>Funds>iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology

  1. All
  2. Commentary
  3. Headlines
  1. Fitch Affirms Six German Development Banks at 'AAA'/Stable

    Headlines

    Fri, 6 Mar 2015

    The Outlook on the Long-term IDR is Stable. The affected banks are KfW, Landwirtschaftliche Rentenbank (Rentenbank), NRW.BANK, Investitionsbank Berlin ( IBB ), Investitionsbank Schleswig-Holstein (IB.SH) and Landeskreditba

  2. From Barron’s, February 2, 2015 (Part 1)

    Commentary

    Sat, 31 Jan 2015

    Bank of China [3988.hk], WynnMacau [1128.hk], SJMHoldings [880.hk], Singapore REITs . Short – SOXX, SOCL, IBB , Australian dollar Herro: Cie.FinanciereRichmont [CFR.sw], DEO, TM, BNPParibas [BNP.fr] Shafer: CCOI, NICE

  3. What to own, not own, when rates go up?

    Commentary

    Fri, 26 Dec 2014

    I really like VNQ, should I sell before rates go up? Will XLU be killed? What about IBB ? Probably don't want bonds, or treasuries, like: EDV, TLT, or BOND? Any thoughts?

  4. Why the Short-Term Tumult?

    Headlines

    Mon, 28 Apr 2014

    rose 32.4%. Possibly the most dramatic example of momentum loss is in the biotechnology sector. The iShares NASDAQ Biotechnology ( IBB ), an exchange-traded fund, appreciated 65% in 2013. From the start of 2014 through February, the

  5. HQH/HQL

    Commentary

    Fri, 18 Apr 2014

    the biotechs, including HQH/HQL. The Nasdaq Biotech Index (^NBI) is down 19% from the late February highs, along with IBB , a benchmark ETF, and the CEFs, when the latter are adjusted for distributions. They all seem to have stabilized this week

  6. From Barron’s, March 24, 2014 (Part 2)

    Commentary

    Sat, 22 Mar 2014

    that for longer-term, go passive for stock funds and active for bond funds. Pg 35: Biotechs are hot and the related ETFs [ IBB , XBI ] are attracting huge inflows [YTD inflows are already more than those for entire 2013]. The P/E of XBI is 33 excluding

  7. Biotech IPOs: What to Learn from a Banner Year

    Headlines

    Thu, 23 Jan 2014

    including Epizyme, Agios Pharmaceuticals and Chimerix. Because the index serves as the basis for the iShares Nasdaq Biotechnology Index Fund, which is an exchange traded fund (ETF), any company added to it automatically gains access

  8. Zacks.com

    Commentary

    Sat, 7 Dec 2013

    Pacific (Emerging) ETFs, Financials, and two Small Cap ETFs came up also but the big category turned out to be HealthCare. IBB at 12.23%, BBH up 11.71% and XBI up 12.21% to name a few. I counted 12 ETFs up over 6% in the 1 Mon (%). I'm

  9. Fidelity Select Biotechnology (FBIOX) -- Outlook positive

    Commentary

    Thu, 28 Nov 2013

    time, and on this Thanksgiving Day, I give thanks to Rajiv Kaul, the smart PM who runs it. I continue to have a high level of confidence in Kaul and this sector fund. I also own IBB , but prefer smart active management when I can find it.

  10. What Investors Were Researching in September

    Headlines

    Sun, 13 Oct 2013

    Alerian MLP AMLP 1.7% iShares Core S&P Small-Cap IJR 6.2% Vanguard Total Bnd Mkt BND 1.0% iShares Nasdaq Biotech IBB 8.2% Vanguard Extended Mkt Index VXF 6.0% Vanguard Info Tech VGT 3.9% Source: Morningstar, Data as of Sept. 30

« Prev12Next »
Content Partners